Citi Upgrades CRISPR Therapeutics (CRSP) to Buy 'given shares have declined ~30% since May 2023'
Tweet Send to a Friend
(Updated - August 17, 2023 2:27 PM EDT)
Citi analyst Yigal Nochomovitz upgraded CRISPR Therapeutics (NASDAQ: CRSP) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Yigal Nochomovitz upgraded CRISPR Therapeutics (NASDAQ: CRSP) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
